Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease
Identifieur interne : 002C41 ( Main/Exploration ); précédent : 002C40; suivant : 002C42Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease
Auteurs : Susan Fox [Royaume-Uni, Canada] ; Montague Silverdale [Royaume-Uni] ; Mark Kellett [Royaume-Uni] ; Rhys Davies [Royaume-Uni] ; Malcolm Steiger [Royaume-Uni] ; Nicholas Fletcher [Royaume-Uni] ; Alan Crossman [Royaume-Uni] ; Jonathan Brotchie [Royaume-Uni, Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-05.
English descriptors
- KwdEn :
Abstract
Opioid peptide transmission is enhanced in the striatum of animal models and Parkinson's disease (PD) patients with levodopa‐induced motor complications. Opioid receptor antagonists reduce levodopa‐induced dyskinesia in primate models of PD; however, clinical trials to date have been inconclusive. A double‐blind, placebo controlled, crossover design study in 14 patients with PD experiencing motor fluctuations was carried out, using the non‐subtype‐selective opioid receptor antagonist naloxone. Naloxone did not reduce levodopa‐induced dyskinesia. The duration of action of levodopa was increased significantly by 17.5%. Non‐subtype‐selective opioid receptor antagonism may prove useful in the treatment of levodopa‐related wearing‐off in PD but not in dyskinesia. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10693
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001A85
- to stream Istex, to step Curation: 001A85
- to stream Istex, to step Checkpoint: 000D58
- to stream Main, to step Merge: 003002
- to stream Main, to step Curation: 002C41
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease</title>
<author><name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
</author>
<author><name sortKey="Silverdale, Montague" sort="Silverdale, Montague" uniqKey="Silverdale M" first="Montague" last="Silverdale">Montague Silverdale</name>
</author>
<author><name sortKey="Kellett, Mark" sort="Kellett, Mark" uniqKey="Kellett M" first="Mark" last="Kellett">Mark Kellett</name>
</author>
<author><name sortKey="Davies, Rhys" sort="Davies, Rhys" uniqKey="Davies R" first="Rhys" last="Davies">Rhys Davies</name>
</author>
<author><name sortKey="Steiger, Malcolm" sort="Steiger, Malcolm" uniqKey="Steiger M" first="Malcolm" last="Steiger">Malcolm Steiger</name>
</author>
<author><name sortKey="Fletcher, Nicholas" sort="Fletcher, Nicholas" uniqKey="Fletcher N" first="Nicholas" last="Fletcher">Nicholas Fletcher</name>
</author>
<author><name sortKey="Crossman, Alan" sort="Crossman, Alan" uniqKey="Crossman A" first="Alan" last="Crossman">Alan Crossman</name>
</author>
<author><name sortKey="Brotchie, Jonathan" sort="Brotchie, Jonathan" uniqKey="Brotchie J" first="Jonathan" last="Brotchie">Jonathan Brotchie</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:52F56D397EBA2B6D95AB6074B842C51C4617AED1</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.10693</idno>
<idno type="url">https://api-v5.istex.fr/document/52F56D397EBA2B6D95AB6074B842C51C4617AED1/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A85</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A85</idno>
<idno type="wicri:Area/Istex/Curation">001A85</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D58</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D58</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Fox S:non:subtype:selective</idno>
<idno type="wicri:Area/Main/Merge">003002</idno>
<idno type="wicri:Area/Main/Curation">002C41</idno>
<idno type="wicri:Area/Main/Exploration">002C41</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease</title>
<author><name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country>Canada</country>
<wicri:regionArea>Movement Disorders Clinic, Toronto Western Hospital, 399 Bathurst St., MP11, Toronto, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Silverdale, Montague" sort="Silverdale, Montague" uniqKey="Silverdale M" first="Montague" last="Silverdale">Montague Silverdale</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Current Address: Department of Neurology, Hope Hospital, Salford</wicri:regionArea>
<wicri:noRegion>Salford</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kellett, Mark" sort="Kellett, Mark" uniqKey="Kellett M" first="Mark" last="Kellett">Mark Kellett</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Current Address: Department of Neurology, Hope Hospital, Salford</wicri:regionArea>
<wicri:noRegion>Salford</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Davies, Rhys" sort="Davies, Rhys" uniqKey="Davies R" first="Rhys" last="Davies">Rhys Davies</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Current Address: University Neurology Unit, Addenbrooke's Hospital, Cambridge</wicri:regionArea>
<wicri:noRegion>Cambridge</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Steiger, Malcolm" sort="Steiger, Malcolm" uniqKey="Steiger M" first="Malcolm" last="Steiger">Malcolm Steiger</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Fletcher, Nicholas" sort="Fletcher, Nicholas" uniqKey="Fletcher N" first="Nicholas" last="Fletcher">Nicholas Fletcher</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Crossman, Alan" sort="Crossman, Alan" uniqKey="Crossman A" first="Alan" last="Crossman">Alan Crossman</name>
<affiliation wicri:level="4"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Manchester Movement Disorders Laboratory, University of Manchester, Manchester</wicri:regionArea>
<placeName><settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
<settlement type="city">Manchester</settlement>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
</author>
<author><name sortKey="Brotchie, Jonathan" sort="Brotchie, Jonathan" uniqKey="Brotchie J" first="Jonathan" last="Brotchie">Jonathan Brotchie</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>The Walton Centre for Neurology and Neurosurgery, Liverpool</wicri:regionArea>
<wicri:noRegion>Liverpool</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Current Address: Toronto Western Research Institute, Toronto Western Hospital, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-05">2004-05</date>
<biblScope unit="volume">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="554">554</biblScope>
<biblScope unit="page" to="560">560</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">52F56D397EBA2B6D95AB6074B842C51C4617AED1</idno>
<idno type="DOI">10.1002/mds.10693</idno>
<idno type="ArticleID">MDS10693</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term>
<term>dyskinesia</term>
<term>motor fluctuations</term>
<term>naloxone</term>
<term>opioids</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Opioid peptide transmission is enhanced in the striatum of animal models and Parkinson's disease (PD) patients with levodopa‐induced motor complications. Opioid receptor antagonists reduce levodopa‐induced dyskinesia in primate models of PD; however, clinical trials to date have been inconclusive. A double‐blind, placebo controlled, crossover design study in 14 patients with PD experiencing motor fluctuations was carried out, using the non‐subtype‐selective opioid receptor antagonist naloxone. Naloxone did not reduce levodopa‐induced dyskinesia. The duration of action of levodopa was increased significantly by 17.5%. Non‐subtype‐selective opioid receptor antagonism may prove useful in the treatment of levodopa‐related wearing‐off in PD but not in dyskinesia. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Manchester</li>
</region>
<settlement><li>Manchester</li>
</settlement>
<orgName><li>Université de Manchester</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
</noRegion>
<name sortKey="Brotchie, Jonathan" sort="Brotchie, Jonathan" uniqKey="Brotchie J" first="Jonathan" last="Brotchie">Jonathan Brotchie</name>
<name sortKey="Crossman, Alan" sort="Crossman, Alan" uniqKey="Crossman A" first="Alan" last="Crossman">Alan Crossman</name>
<name sortKey="Davies, Rhys" sort="Davies, Rhys" uniqKey="Davies R" first="Rhys" last="Davies">Rhys Davies</name>
<name sortKey="Davies, Rhys" sort="Davies, Rhys" uniqKey="Davies R" first="Rhys" last="Davies">Rhys Davies</name>
<name sortKey="Fletcher, Nicholas" sort="Fletcher, Nicholas" uniqKey="Fletcher N" first="Nicholas" last="Fletcher">Nicholas Fletcher</name>
<name sortKey="Kellett, Mark" sort="Kellett, Mark" uniqKey="Kellett M" first="Mark" last="Kellett">Mark Kellett</name>
<name sortKey="Kellett, Mark" sort="Kellett, Mark" uniqKey="Kellett M" first="Mark" last="Kellett">Mark Kellett</name>
<name sortKey="Silverdale, Montague" sort="Silverdale, Montague" uniqKey="Silverdale M" first="Montague" last="Silverdale">Montague Silverdale</name>
<name sortKey="Silverdale, Montague" sort="Silverdale, Montague" uniqKey="Silverdale M" first="Montague" last="Silverdale">Montague Silverdale</name>
<name sortKey="Steiger, Malcolm" sort="Steiger, Malcolm" uniqKey="Steiger M" first="Malcolm" last="Steiger">Malcolm Steiger</name>
</country>
<country name="Canada"><noRegion><name sortKey="Fox, Susan" sort="Fox, Susan" uniqKey="Fox S" first="Susan" last="Fox">Susan Fox</name>
</noRegion>
<name sortKey="Brotchie, Jonathan" sort="Brotchie, Jonathan" uniqKey="Brotchie J" first="Jonathan" last="Brotchie">Jonathan Brotchie</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C41 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C41 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:52F56D397EBA2B6D95AB6074B842C51C4617AED1 |texte= Non‐subtype‐selective opioid receptor antagonism in treatment of levodopa‐induced motor complications in Parkinson's disease }}
This area was generated with Dilib version V0.6.29. |